NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer. by Özeş, Ali R. et al.
NF-κB-HOTAIR axis links DNA damage response, 
chemoresistance and cellular senescence in ovarian cancer
Ali R. Özeş1, David F. Miller2, Osman N. Özeş3, Fang Fang2, Yunlong Liu4,5,6, Daniela 
Matei6,7,8, Tim Huang9, and Kenneth P. Nephew1,2,6,8,10,*
1Molecular and Cellular Biochemistry Department, Indiana University, Bloomington, IN 47405, 
USA
2Medical Sciences Program, Indiana University School of Medicine, Bloomington, IN 47405, USA
3Department of Medical Biology and Genetics, Akdeniz University, Antalya, Turkey
4Department of Medical and Molecular Genetics, Indiana University School of Medicine, 
Indianapolis, Indiana 46202, USA
5Center for Computational Biology and Bioinformatics, Indianapolis, Indiana 46202, USA
6Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana 46202, USA
7Department of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, USA
8Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, 
IN, 46202, USA
9Department of Molecular Medicine/Institute of Biotechnology, The University of Texas Health 
Science Center at San Antonio, San Antonio, TX, 78229-3900
10Department of Cellular and Integrative Physiology, Indiana University School of Medicine, 
Indianapolis, IN 46202, USA
Abstract
The transcription factor nuclear factor kappa B (NF-κB) and the long non-coding RNA (lncRNA) 
HOTAIR (HOX transcript antisense RNA) play diverse functional roles in cancer. In this study, we 
show that upregulation of HOTAIR induced platinum resistance in ovarian cancer, and increased 
HOTAIR levels were observed in recurrent platinum-resistant ovarian tumors vs. primary ovarian 
tumors. To investigate the role of HOTAIR during DNA damage induced by platinum, we 
monitored double-strand breaks and show that HOTAIR expression results in sustained activation 
of DNA damage response after platinum treatment. We demonstrate that ectopic expression of 
HOTAIR induces NF-κB activation during DNA damage response and MMP-9 and IL-6 
expression, both key NF-κB target genes. We show that HOTAIR regulates activation of NF-κB by 
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decreasing Iκ-Bα (NF-κB inhibitor) and establish that by inducing prolonged NF-κB activation 
and expression of NF-κB target genes during DNA damage, HOTAIR plays a critical role in 
cellular senescence and platinum sensitivity. Our findings suggest that a NF-κB-HOTAIR axis 
drives a positive-feedback loop cascade during DNA damage response and contributes to cellular 
senescence and chemotherapy resistance in ovarian and other cancers.
Introduction
The mammalian DNA damage response (DDR) to genotoxic stress is critically important for 
maintaining genome stability, cell survival and preventing cellular transformation. DDR 
networks include the classic tumor suppressor gene p53 and its downstream target p21 [1]. 
More recently, a DDR mechanism has been reported involving nuclear factor kappa B (NF-
κB), a master regulator of over 400 genes involved in inflammation, apoptosis, cell cycle 
control and cell senescence [2, 3]. NF-κB signaling-mediated activation of DDR has been 
shown to restore genomic integrity, augment cancer cell survival, and play a role in 
development of resistance to platinum-based cancer therapies [4, 5]. However, distinct DNA 
damage-induced NF-κB signaling pathways contributing to chemoresistance in cancer have 
not been well studied.
Platinum, the first line of therapy for ovarian and other cancers, induces inter-and-intra 
strand crosslinks, generates single stranded breaks and activates nucleotide excision repair 
[6]. Cellular responses to DNA damage, including response to platinum, can be regulated at 
the post-transcriptional level by long noncoding RNAs (lncRNAs) [7] . The JADE1 adjacent 
regulatory RNA (lncRNA-JADE) was reported to play a crucial role in DNA damage-
induced, histone H4 acetylation associated with transcriptional activation [8], and lncRNA-
p21 was shown to physically interact with hnRNPK (heterogenous nuclear ribonuclear 
proteins) during DDR and mediate p53-dependent transcriptional repression [9]. Platinum-
induced DNA damage resulted in lncRNA PANDA (p21-associated ncRNA DNA damage 
activated) activation, interaction with transcription factor NF-YA, and PANDA-NF-YA 
modulation of p53-dependent apoptosis [10].
HOX antisense intergenic RNA (HOTAIR), a lncRNA frequently overexpressed in human 
cancers [11], was originally identified in 2007 by Rinn et al as a lncRNA located in the 
HOXC cluster on chromosome 12 that regulates the HOXD gene cluster on chromosome 2 
[12]. HOTAIR transcriptionally silences genes located on a distant chromosome region 
through an epigenetic mechanism involving interaction with polycomb repressive complex 2 
(PRC2) [7] . This interaction appears to be required for PRC2 occupancy of specific loci, 
such as the HOXD locus, trimethylation of histone H3 lysine K27 (H3K27me3) by enhancer 
of zeste 2 (EZH2) and subsequent gene repression [12, 13]. Additional inter-chromosomal 
targets of HOTAIR include- cancer-associated genes such as protocadherin (PCDH), ephrin 
receptor (EPHA1) and the NF-κB inhibitory protein Iκ-Bα [12, 14]. Although epigenetic 
processes have been reported to play critical roles in DDR [15], including aberrant histone 
methylation by EZH2 [16, 17], a direct role for HOTAIR in DDR has not been investigated. 
However, functional overlap between PRC2 and NF-κB activation by genotoxic agents, 
inflammation, and cancer has been reported [18], suggesting a potential interaction between 
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NF-κB activation and HOTAIR in response to DNA damage. Furthermore, in solid tumors, 
including ovarian cancer (OC), enhanced NF-κB activation has been observed in aggressive 
chemoresistant cell lines [19].
The objective of this study was to investigate the functional role for HOTAIR in DDR and 
chemotherapy resistance. We demonstrate a strong correlation of HOTAIR overexpression 
with platinum resistance in OC cell lines and patient tumors. In response to DNA damage, 
we found that NF-κB directly upregulates HOTAIR expression in OC cell lines. 
Downregulation of Iκ-Bα during DDR induced a NF-κB-HOTAIR signaling positive-
feedback loop cascade, and we demonstrate that DDR further induces HOTAIR-mediated 
expression of p65-NF-κB and NF-κB target genes MMP9 and IL-6 to promote OC cellular 
senescence and resistance to DNA-damaging agents. Collectively, these results are the first 
to demonstrate a role for HOTAIR in DNA damage-induced NF-κB signaling pathway, 
identifying HOTAIR as a new therapeutic target in drug resistant OC and likely other 
cancers.
Results
HOTAIR is overexpressed in drug-resistant ovarian cancer
We examined expression of HOTAIR in a panel of OC cell lines (Fig. 1A) representing a 
spectrum of platinum (CDDP) sensitivity (Resistant; Sensitive). Increased (P<0.05) 
HOTAIR expression was observed in CDDP- resistant (IC50 levels >10µM) compared to -
sensitive cell lines (Fig. 1A, Supplementary Table S1) and in OC tumors obtained from 
unpaired patients with CDDP-resistant vs. -sensitive high-grade serous disease (2.1 log2 fold 
change; Fig. 1B). We then examined patient data obtained from The Cancer Genome Atlas 
(TCGA; publically available expression and clinical annotation data) [20]. HOTAIR 
expression was increased (>0.5 log10 fold-change) in OC patients with recurrent compared 
to primary high-grade serous disease (Fig. 1C).
Overexpression of HOTAIR increases colony formation and CDDP resistance
To further examine the association between HOTAIR expression and chemoresistance, we 
either overexpressed (80-fold increase vs. control; Supplementary Fig. S1A) HOTAIR in 
CDDP-sensitive A2780p or HEYC2 (moderate HOTAIR levels) or knocked-down (70% 
reduction compared to dsiGFP control, Supplementary Fig. S1B) HOTAIR in CDDP-
resistant A2780_CR5 and examined functional changes using clonogenic and proliferation 
assays in vitro and a mouse xenograft model in vivo. HOTAIR overexpression increased 
(P<0.05) whereas HOTAIR knockdown decreased (P<0.05) OC clonogenic survival (Fig. 1D 
and Supplementary Fig. S1C). However, overexpression or knockdown of HOTAIR had no 
effect on cell doubling time (Supplementary Fig. S1D, E), indicating that cell proliferation 
rate was not altered. To test whether HOTAIR overexpression contributed to CDDP 
resistance in vivo, A2780p were transfected with either HOTAIR or vector control, treated 
with CDDP or vehicle to induce DNA damage, and then injected subcutaneously in nude 
mice (see Methods). Tumor size was measured biweekly. Tumor growth, measured by 
assessing area under the curve (AUC) of the xenograft tumor, was greater (P<0.05) for 
HOTAIR overexpressing OC tumors compared to control (Fig. 1E; Supplementary Fig. 
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S1F), indicating a role for HOTAIR overexpression in response to DNA damaging agents 
and CDDP resistance.
HOTAIR mediates DNA damage response (DDR) in ovarian cancer cells
We observed that CDDP treatment of A2780p cells increased (P<0.05) HOTAIR expression 
starting at 16 hr post treatment (Supplementary Fig. S2A) and that HOTAIR expression was 
also increased by other DNA damage agents mitomycin C and hydrogen peroxide (MMC 
and H2O2; Supplementary Fig. S2B, C). To further examine a role for HOTAIR as a 
potential mediator of DDR, we examined known cellular responses to genotoxic stress and 
apoptosis [21] after platinum treatment, including phosphorylation of Chk1 (pChk1), 
formation of γ-H2AX foci, and caspase cleavage. A2780p cells overexpressing HOTAIR or 
A2780_CR5 cells transfected with dsiRNA HOTAIR were treated with CDDP. HOTAIR 
overexpression increased s317 phosphorylation of Chk1, a marker for Chk1 activation, in 
A2780p (Fig. 2A and Supplementary Fig. S2D), whereas HOTAIR knockdown decreased 
Chk1 s317 phosphorylation in A2780_CR5 (Fig. 2B and Supplementary Fig. S2E). 
Interestingly, in the Kuramochi OC cell line harboring p53D281Y mutant (DNA binding 
mutant), phosphorylation of both p53 and Chk1 was induced by HOTAIR overexpression 
(Supplementary Fig. S2F). No expression of p21 was observed (data not shown), confirming 
inactive p53 (Supplementary Table S1). pChk1 levels correlated with γ-H2AX 
phosphorylation, and the percentage of cells containing >5 γ-H2AX foci increased (1.5 and 
4 fold) by 1 and 24 hr of CDDP exposure in HOTAIR overexpressing A2780p cells (Fig. 
2C) and decreased in A2780_CR5 cells (2.3 and 1.5 fold) by 1 and 24 hr (Fig. 2D). The 
number of γ-H2AX foci was unchanged in untreated cells (Supplementary Fig. S2G). 
Furthermore, enforced overexpression of HOTAIR in A2780p decreased caspase 3/7 
cleavage (Fig. 2E; left) and increased caspase 3/7 cleavage in A2780_CR5 cells transfected 
with dsiRNA HOTAIR (Fig. 2E; right), an established characteristic of cells undergoing 
apoptosis, indicating that HOTAIR overexpression inhibited platinum-induced apoptosis.
Overexpression of HOTAIR leads to specific changes in gene expression
To investigate the association between HOTAIR, DDR and chemoresistance and identify 
genes and pathways affected by HOTAIR overexpression, we performed whole 
transcriptome RNA-sequencing of A2780p (CDDP-sensitive) and A2780_CR5 (CDDP-
resistant and endogenous HOTAIR overexpression) OC cell lines. Marked differences in 
overall gene expression profiles were observed between the paired lines (Supplementary Fig. 
S3A, B), and expression of DDR-associated genes (e.g., MLH1 and XRCC3), NF-κB 
pathway (e.g., IL6R, IL4R, NCAM, BCL2L211) and epigenetic regulators (i.e., PRC-
associated genes) were prominently altered in A2780_CR5 compared to A2780p 
(Supplementary Fig. S3C). As expected, differential expression of cancer relevant cellular 
processes and pathways associated with chemoresistance (anti-apoptotic, cell adhesion, 
inflammation) in these cell lines was also observed, including the NF-κB pathway 
(Supplementary Fig. S3B). Further examination of the highly enriched NF-κB pathway by 
western blot analysis confirmed that total p65 nuclear levels were increased (3.2-fold vs. 
A2780p) in A2780_CR5 (Fig. 3A).
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To validate NF-κB activation by HOTAIR, we measured Iκ-Bα levels in A2780p cells 
overexpressing HOTAIR treated with CDDP (Fig. 3B). We observed Iκ-Bα protein levels 
decreased indicating that by repressing the inhibitory Iκ-Bα unit, HOTAIR can activate NF-
κB during DDR. Next we measured nuclear p65-NF-κB expression in A2780p HOTAIR 
overexpressing and A2780_CR5 dsiHOTAIR knockdown cells using immunofluorescence 
(IF) and western blotting. We observed a 2-fold increase in NF-κB translocation 1 and 24 hr 
post-CDDP treatment in A2780 cells (Fig. 3C), and an increase in nuclear p65 and decrease 
in both nuclear and cytoplasmic Iκ-Bα in the western blot (Fig. 3D). Additionally, we 
observed a 3 and 5 fold decrease in NF-κB translocation 1 and 24 hr post-CDDP treatment 
in A2780_CR5 cells (Fig. 3E) and a decrease in nuclear p65 and increase in cytoplasmic Iκ-
Bα levels with western blotting (Fig. 3F), indicating that HOTAIR expression promotes 
sustained NF-κB activation during DDR.
To further investigate the role of NF-κB transcriptional activity in stress (genotoxic)-induced 
HOTAIR expression (Supplementary Fig. 2A, B and C) A2780p cells were treated with 
CDDP. As shown in Fig. 4A, an increase in HOTAIR expression was observed (9-fold) at 24 
hr post-CDDP treatment and co-treatment with an NF-κB inhibitor (Bay-11) inhibited 
(P<0.001) CDDP-induced HOTAIR expression. TNF-α treatment increased (P<0.05) 
expression of HOTAIR (16-fold by 2 hr; Supplementary Fig. 4A) and ectopic overexpression 
of two known inducers of NF-κB, IKK-α and IKK-β [22], increased (p<0.05) HOTAIR 
expression (3-fold; Fig. 4B). Furthermore, in A2780p ectopically overexpressing HOTAIR, 
NF-κB targets IL-6, and MMP9 were upregulated (P<0.05) while expression of these genes 
was reduced (P<0.05) in HOTAIR knockdown-A2780_CR5 (Fig. 4C). Moreover, in 
xenograft OC tumors overexpressing HOTAIR, CDDP treatment increased overall 
expression of HOTAIR and NF-κB target genes, with IL-6 and MMP9 upregulation 
(P<0.05) relative to tumors derived from untreated OC cells (Fig. 4D), confirming 
functionality of the pathway in vivo and stable gene expression changes‥
Our findings that HOTAIR expression was increased hours post-DNA damage and this 
induced expression was blocked by inhibition of NF-κB activation (Supplementary Fig. 2A) 
indicated transcriptional regulation of the lncRNA in a NF-κB/DNA damage-dependent 
manner. To begin to determine the underlying mechanism, we used promoter-binding assays 
to examine the HOTAIR promoter region (1 kb upstream of transcription start site (TSS)). 
We identified a putative p65-NF-κB binding site (906-GGGACACCCC-915) (Fig. 5A) and 
investigated NF-κB-p65 binding to the HOTAIR promoter region in A2780_CR5 cells using 
chromatin immunoprecipitation (ChIP) with five different primer sets (1, 10kb; 2, 8kb, 3, 
4kb; 4: 900 bp; 5, 200 bp from the TSS) spanning 10kb upstream of the TSS (Fig. 5B). 
Enrichment (4-fold) of p65 in the canonical binding site (primers 4 & 5) was observed 
compared to control primer 1 (Fig. 5B), further supporting a regulatory role for NF-κB 
pathway in HOTAIR expression. Next, we measured p65-NF-κB binding to the HOTAIR 
promoter in A2780p cells treated with CDDP in the presence and absence of Bay-11. 
Enrichment (5.2 fold) of p65 in the canonical binding site 4 was observed compared to 
control primer (Fig. 5C) and abolished in the presence of Bay-11.
To further examine the transcriptional activation of HOTAIR by p65-NF-κB, transient 
transfection assays were performed in 293 cells using wild-type or mutant (906-
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CTCATTCTCA-915) sequences of HOTAIR promoter along with renilla vector. As shown 
in Supplementary Fig. S4B, treatment with TNF-α increased (p<0.05) luciferase activity 
(1.6-fold) by the p65-NF-κB wild-type vector, no change in activity of the mutant promoter 
was observed, and TNF-α-induced luciferase activity was blocked (P<0.05) by NF-κB 
inhibitor Bay-11.
Regulation of HOTAIR expression by NF-κB during DDR
To examine the effect of additional DNA damaging agents on NF-κB activation, we used a 
previously reported luciferase reporter construct containing 861 base pairs of the E-selectin 
promoter containing 3 canonical NF-κB-p65-binding sites as a positive control [23]. TNF-α 
treatment increased luciferase activity compared to empty vector (Supplementary Fig. S4C), 
confirming luciferase activation by known NF-κB inducers. In cells treated with MMC, 
H2O2 or CDDP, we observed increased luciferase activity, suggesting that various types of 
DNA damage can activate NF-κB (Supplementary Fig. S4D). To determine NF-kB specific 
transcription luciferase activity was determined in p65-wt or -mutant vector transfected 
A2780p cells (described in Supplementary Fig. S4D) treated with MMC, H2O2 or CDDP. As 
shown in Fig. 5D, p65-wt HOTAIR promoter activity was increased by these genotoxic 
agents (6.9-, 8.2- and 5.0-fold by MMC, CDDP, or H2O2 relative to empty vector 
respectively) and was inhibited (P<0.05) by pretreatment with Bay-11 (Fig. 5E). No change 
in luciferase activity was observed with the p65-mutant construct relative to wild-type vector 
(Fig. 5D, E). In all, our results suggest that HOTAIR is transcriptionally regulated by NF-κB 
as a response to DNA damage.
Overexpression of HOTAIR induces IL-6 secretion, DDR activation and cellular senescence
Cytokines in the microenvironment contribute to DNA damage resistance [24] and secretion 
of cytokines during persistent DNA damage has been reported [25]. IL-6 secretion in 
particular was shown to contribute to a “chemoresistant niche” [26]. Having observed 
significant expression of interleukin receptors in A2780_CR5 (Fig. 3B), indicative of 
pathway activation, we performed an NF-κB target cytokine screen. HOTAIR 
overexpression was associated with increased (>2-fold) secretion of CCL5, IL-5, IL-6, 
CXCL-11 and IL-23 compared to vector control (Supplementary Fig. S5A). Moreover, 
treatment of A2780p cells with “HOTAIR-conditioned” media increased (P<0.05) CDDP 
IC50 by >2-fold, which was reversed using an IL-6 neutralizing antibody (Fig. 6A). The 
addition of recombinant IL-6 to unconditioned media resulted in an approximate 2-fold 
increase (P<0.05) in the IC50 for CDDP (Fig. 6B), and dsiRNA knockdown of HOTAIR in 
A2780_CR5 cells reduced (P<0.05) IL-6 secretion (Fig. 6C) and IC50 for CDDP (Fig. 6D). 
Recombinant IL-5 had no effect on CDDP IC50 (Supplementary Fig. S5B), further 
indicating a role for HOTAIR-mediated IL-6 induction in platinum-DNA damage response.
Based on a recent report that unresolved DNA strand breaks (DSBs) caused by DNA 
damage followed by NF-κB activation and IL-6 secretion can induce cellular senescence 
[25], we examined whether treatment with low (1µM CDDP or 1/10th of IC50) or high 
(20µM CDDP or 2X the IC50) doses of CDDP induce senescence in A2780p cells 
overexpressing HOTAIR or not. Activation of p53 and p21 by HOTAIR was observed only 
during high CDDP treatment, indicated by p53 phosphorylation and p21 expression (Fig. 
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6E). In addition, IL-6 secretion, an established marker for cell senescence [25, 27], was 
increased (P<0.05) by CDDP in A2780p overexpressing HOTAIR compared to vector 
transfected cells (Supplementary Fig. S5C). Based on the observation that addition of 
recombinant IL-6 increased (P<0.05) proliferation (Supplementary Fig. S5D), we reasoned 
that IL-6 secretion by senescent cells induced proliferation of neighboring cells.
We then investigated whether increase in p-Chk1 and p-p53 was dependent on ATR 
signaling (ataxia telangiectasia mutated (ATM) and Rad3-related (ATR) signaling pathway) 
[28]. In HOTAIR overexpressing vs. vector control cells, decreased p-p53 levels (Fig. 7A, 
left) was observed and the level of p-Chk1 was essentially unchanged (Fig. 7A, right), 
suggesting ATR-dependent activation of p53 by HOTAIR (further supported by no change in 
proliferation in the presence of ATRi; Supplementary Fig. S5E). Next, we measured p-Chk1 
and p-p53 levels in A2780_CR5 cells upon dsiRNA knockdown HOTAIR and observed 
decreased p-Chk1 and p-p53 levels overall, and this effect was abolished in the presence of 
ATR inhibitor (Supplementary Fig. S5F). To examine lack of p65-NF-kB on cell 
proliferation and CDDP-resistance, we stably knocked down p65-NF-kB and validated 
reduced luciferase activity after stimulation with TNF-α (Supplementary Fig. S6A, B). 
Interestingly, ectopic expression of HOTAIR in NF-κB knockdown cells rescued (P<0.05) 
proliferation and increased (P<0.05) clonogenic survival (Supplementary Fig. S6C, D), 
which may be attributed to the previously described role of HOTAIR in inhibiting p21 as a 
potential mechanism of chemotherapy resistance and evasion of apoptosis [29, 30].
To examine cellular senescence, we measured β-galactosidase activity (SA-β-Gal) [31]. In 
HOTAIR overexpressing A2780p cells, SA-β-Gal positive cell numbers were increased 
(P<0.05) by high vs. low levels of CDDP (Supplementary Fig. S7A), and NF-κB inhibitor 
Bay-11 reduced (P<0.05) the number of senescent cells (Fig. 7B), which is likely a 
cytostatic effect of the drug (and not cytotoxicity), based on the observation that ectopic 
expression of HOTAIR increased cell proliferation in cells treated with the NF-κB inhibitor 
(Supplementary Fig. S5C). DsiRNA knockdown of HOTAIR in A2780_CR5 cells reduced 
the number of senescent cells (Fig. 7C). Next, we performed flow cytometry in both 
HOTAIR expressing A2780p and dsiHOTAIR knockdown A2780_CR5 cells 24 and 48 hr 
post CDDP treatment. We observe a decrease in S1 and an increase in G2 phase 48 hr post 
CDDP treatment in HOTAIR expressing cells (Fig. 7D) and a reversal of this effect in 
A2780_CR5 cells (Fig. 7E) suggesting that a subpopulation of cells undergo HOTAIR-
dependent cell senescence. Collectively, these results indicate that HOTAIR-induced NF-κB 
activation and IL-6 secretion contributes to a senescent phenotype, and IL-6 secretion 
influences the surrounding cell population in a paracrine manner, contributing to 
chemoresistance (Supplementary Fig. S7C).
Discussion
HOTAIR is a lncRNA frequently overexpressed in solid tumors [32] and associated with 
cancer cell growth and migration. Although HOTAIR overexpression in OC correlates with 
disease metastasis and poor patient prognosis [12, 33, 34], the underlying mechanism of 
HOTAIR upregulation and the role of this important lncRNA in drug resistance in OC and 
other cancers is not fully understood. In this study, we demonstrate a key role for HOTAIR 
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in DNA damage: HOTAIR modulates expression of genes activated during DDR, including 
Chk1 and the levels of γ-H2AX, to inhibit cell cycle progression. Our findings include that 
HOTAIR activation of the NF-κB pathway following CDDP-induced DNA damage 
contributes to cellular senescence. Furthermore, we demonstrate that DDR activation of NF-
κB induces HOTAIR and a positive feedback loop, resulting in sustained NF-κB activation 
and persistent DNA damage signaling. As platinum-based regimens continue to be the 
mainstay of treatment for many solid cancers including OC [35], HOTAIR may represent a 
target for therapeutic intervention of drug resistance.
Previous mapping studies revealed HOTAIR binding to chromosomal regions near the Iκ-
Bα gene, supporting the potential regulation of NF-κB activity by HOTAIR. NF-κB is a 
master regulator of several cellular responses, including DDR, stress, senescence and 
inflammation, although its role in cancer is paradoxical, including both oncogenic and tumor 
suppressive activities [36]. In ovarian and other cancers, NF-κB activation is associated with 
chemoresistance [37, 38] and activation during DNA damage induced by genotoxic agents 
has been demonstrated but not well defined [4, 5]. We show that HOTAIR expression 
modulated NF-κB activation as well as multiple NF-κB target genes including IL-6 and 
MMP-9 in vitro as well as in vivo. Consistent with these results, overexpression of HOTAIR 
increased nuclear translocation of NF-κB, which correlated with reduced total Iκ-Bα levels 
after CDDP treatment, and HOTAIR overexpression resulted in sustained DDR and NF-κB 
activation.
Our results also link HOTAIR-mediated IL-6 secretion with platinum resistance (Fig. 6A). 
The IL-6 cytokine induces apoptosis inhibitors BCL-2, BCL-XL and XIAP and contributes 
to CDDP-resistance [39]. Importantly, IL-6 secretion has also been linked with exposure to 
genotoxic stress caused by cisplatin and carboplatin [40]. IL-6 is generally considered a pro-
survival cytokine, but sustained IL-6 secretion after DNA damage is linked with cellular 
senescence [36]. The notion of cell senescence (a tumor suppressor mechanism) contributing 
to chemotherapy resistance (involves cell proliferation) is an emerging concept. Recent 
reports suggest that a senescent cell can become a “pro-inflammatory cell” and promote 
tumor progression by acquiring a senescence associated secretory phenotype (SASP) offer 
support for this concept [41, 42]. Our findings that HOTAIR can activate NF-kB and its 
target genes is supported by a recent report implicating HOTAIR in driving the expression of 
genes directly involved in SASP in urothelial carcinoma, further potentiating an important 
role for HOTAIR during senescence [43]. Furthermore, it is now strongly believed that the 
secretion of IL-6 by senescent cells can alter the tumor microenvironment in a paracrine 
fashion, activating multiple pathways, including the epithelial to mesenchymal transition 
(EMT) [44], and transforming surrounding stromal cells to a more chemoresistant phenotype 
[25, 26] (Supplementary Fig. S7B). Our findings on HOTAIR, IL-6, and DNA damage-
induced cell senescence are consistent with previous reports associating HOTAIR expression 
with EMT [33, 34], suggesting promotion of EMT by HOTAIR during chemotherapy-
induced DNA damage may contribute to chemoresistance. The slow tumor growth we 
observed in CDDP-treated HOTAIR expressing cells (Supplementary Fig. S1F) could be 
attributed to senescent cells altering the microenvironment to a tumor promoting 
environment, although further studies are needed.
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Unresolved DSBs generated by prolonged CDDP-induced DNA damage can result in 
constitutive activation of DDR signaling and activation of stress response pathways, 
including senescence [45]. Senescence following irreparable DNA damage has been 
reported [25], and we investigated whether exposure to low or high dose CDDP would be 
analogous to early response (transient period) or development of resistance (prolonged 
period). We demonstrate that prolonged expression of HOTAIR results in γ-H2AX foci 
formation and subsequent activation of Chk1, which plays a pivotal role during DDR by 
inducing S15 phosphorylation of tumor suppressor p53 (trans activation domain). The 
finding that HOTAIR-induced p53 phosphorylation during high CDDP (prolonged exposure) 
is further supported by the observed induction of p21 (Fig. 6D), a p53 target gene and CDK 
inhibitor, a process that is ATR-dependent (Supplementary Fig.S7B). As induction of p21 
has been closely linked to senescence [46], our findings are the first to indicate a role for 
HOTAIR in both senescence and chemoresistance. In support of our data, HOTAIR has 
recently been shown to induce the senescence pathway by its induction of p21 and p15 as 
well as genes involved in the NF-kB pathway [43, 47]. We posit that HOTAIR can contribute 
to the activation of several pathways that ultimately lead to chemoresistance. In high DNA 
damaging conditions a subset of cells can undergo HOTAIR dependent senescence, and at 
lower or non-senescent conditions HOTAIR can cause resistance in a cell-autonomous 
manner.
In addition to demonstrating that the above scenario is a NF-κB pathway dependent process, 
our results indicate that sustained NF-κB activation in HOTAIR expressing cells is due to 
suppression of Iκ-Bα expression by HOTAIR, in agreement with a previous report linking 
NF-κB activation to cellular senescence [2]. Recent studies show prolonged NF-κB 
activation in mutant p53 cells increases inflammation and tumorigenesis, primarily by 
mutant p53 sequestering tumor suppressor DAB2IP in the cytoplasm [48, 49]. Our 
observation that HOTAIR induced phosphorylation of mutant p53 (Supplementary Fig. S2C) 
may provide a mechanistic link for this complex process and support a role for HOTAIR in 
tumorigenesis in p53 mutant OC, the most commonly mutated gene in the high-grade serous 
disease [20]. In addition, it is possible that DNA damage can induce a physical interaction 
between NF-κB and PRC2, which can alter regulation of genes involved during senescence, 
such as an EZH2-NF-κB interaction [18].
Collectively, our data suggest a model (Fig. S7B) of NF-κB-driven transcription of 
HOTAIR, which subsequently activates persistent NF-κB expression, IL-6 secretion, and 
activation of CHK1-p53-p21 pathway, and establishment of a senescence, chemoresistant 
cancer phenotype. Although the involvement of other NF-κB and HOTAIR target genes in 
development of chemoresistance cannot be overlooked, the components of this network, 
including HOTAIR, may represent targets for novel therapeutic strategies to overcome or 
prevent CDDP-resistance in ovarian and other cancers.
Material and Methods
Cell lines, patient samples, culture conditions and reagents
Epithelial OC cell lines (A2780, A2780_CR5, SKOV3, HEYC2, OV90, IOSE, IGROV, 
OVMUNA, OV90) were maintained in RPMI 1640 medium (Invitrogen, Carlsbad, CA) as 
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described previously [50]. Cisplatin-resistant A2780_CR5 was established by continuous 
exposure to increasing concentrations of cisplatin [50]. Cell lines were authenticated in 2012 
by ATCC and tested for mycoplasma contamination (Manassas, VA). High-grade serous 
ovarian tumors (unpaired samples; chemo-naïve, stage 3–4 or recurrent, platinum resistant), 
and ovarian surface epithelium (OSE) were surgically collected with informed consent from 
all subjects (IRB approved protocol IUCRO-0280), snap-frozen, and stored in liquid 
nitrogen [51]. Cisplatin (CDDP) was purchased from Calbiochem (Billerica, MA), 
mitomycin C (MMC) was purchased from Sigma Chemical Co. (St. Louis MO), and H2O2 
was purchased from EMD Millipore (Billerica, MA). NF-κB inhibitor Bay-11–7082 was 
purchased from Santa Cruz Biotech (Santa Cruz, CA). LZRS-HOTAIR was a gift from Dr. 
Howard Chang (Stanford University; Addgene plasmid # 26110). Full-length HOTAIR was 
cloned into pAV5S vector containing a 98-mer aptamer sequence and as a vector control, 
aptamer cloned into pAV5S was used to account for any possible RNA-dependent signaling 
effects [52].
Luciferase assays, DNA damage experiments
A2780p cells were seeded in 96-well plates (104 cells/well) and transfected with pGL3-
promHOTAIR or mutants (500 ng construct/transfection). To normalize transfection 
efficiency, cells were co-transfected with PGL4 Renilla plasmid (100 ng). Twenty-four hours 
after transfection, cells were treated with Bay-11–7082 (5ng/mL for 1h) and then TNF-α 
(10ng/mL), MMC (10µM), CDDP (10µM) or H2O2 (10µM) for indicated times and lysed. 
Luciferase activity was analyzed using the Dual Luciferase Reporter Assay System 
(Promega, Madison, WI) and a Thermo Scientific Multilabel Plate Reader. To induce DNA 
damage, cells were treated with CDDP, MMC, H2O2 at indicated concentrations and 
harvested for RNA and protein isolation at the stated time points. Caspase 3/7 cleavage 
assay was performed according to manufacturers protocol (Caspase 3/7 GloAssay, 
Promega).
Mutagenesis and RNAi
Site directed mutagenesis was performed with the following forward and reverse primer sets 
using the QuickChange protocol by Agilent (Santa Clara, CA). Forward primer 5’-
GTGGTTTATCTTGCACCCCTCATTCTCAAGCCCCAGCCAGGGAA-3’, and reverse 
primer 5’-TTCCCTGGCTGGGGCTTGAGAATGAGGGGTGCAAGATAAACCAC-3’. The 
dsiRNA sequences used targeting human HOTAIR (Sense strand 5’-
UUCUAAAUCCGUUCCAUUCCACUGCGA-3’, and antisense strand 5’-/5Phos/
GCAGUGGAAUGGAACGGAUUUAGAA-3’) or negative control RNA targeting GFP 
(Sense strand 5’-CUACAACAGCCACAACGUC-3’, and antisense strand 5’-/5Phos/
GACGUUGUGGCUGUUGUAG-3’). DsiRNAs were transfected into cells using 
Lipofectamine 2000 (Invitrogen). shRNA for p65 and control were purchased from Santa 
Cruz (Sc-29410-SH, and sc-108060). 48 hr post transfection, A2780p cells were selected 
with 2.5ng/µL puromycin for 5 days and then maintained in 1ng/µL of the drug.
Immunoblot analysis
Cells were lysed in RIPA lysis buffer (50mM Tris-HCl, 150mM NaCl, 1mM EDTA, 1% 
NP-40, 0.5% sodium deoxycholate and 0.1% SDS) supplemented with protease inhibitors 
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(Sigma). Protein (approximately 5–10 µg) was loaded on precast 7.5% TGX gels (BioRad, 
Hercules, CA), blotting was performed as described previously [53] using polyvinylidene 
difluoride (PVDF) membrane (GE Healthcare, Pittsburg, PA). Membranes were blocked, 
incubated overnight at 4°C with primary antibody (EZH2, p21, p53, phospho-p53 (S15), β-
tubulin, Chk1, phospho-Chk1 (S317), Iκ-Bα, phospho-H2A.X, or Lamin-B (See 
Supplementary Table S2), washed, and then incubated with HRP-conjugated secondary 
antibody (Kirkegaard & Perry Laboratories, Gaithersburg, MD), and protein signals were 
observed using a chemiluminescence system (Thermo Scientific, Schaumberg, IL), 
according to instructions provided by the manufacturer.
MTT Assay
The quantity of viable cells was calculated by MTT assay as described previously [53]. 
Absorbance (570 nm; filter reference at 620 nm) was recorded using EnVision Multilabel 
Plate Reader (Perkin Elmer, Waltham, MA). Doubling time was measured with the equation: 
duration*log(2)/(log(final concentration)-log(initial concentration)).
RNA extraction and quantitative RT-PCR (qPCR)
RNA was extracted from cell lines and tumors and using RNeasy kit (Qiagen, Venlo, 
Limburg), cDNA was prepared using MMLV RT system (Promega), and qPCR) was 
performed with total cDNA and primers for indicated genes and GAPDH or EEF1A as the 
endogenous control (Supplementary Table S3), using Applied Biosystems 7500 Fast RT-
PCR system (Life Technologies, Grand Island, NY) and corresponding software, as we have 
described [54].
Cytoplasmic and nuclear extractions
Cells were grown to 80% confluence, trypsinized and centrifuged (1200 RPM, 5 min). Cell 
pellets were washed (1x PBS), re-pelleted (1200 RPM, 5 min), and then lysed in 
cytoplasmic lysis buffer supplemented with protease inhibitors (10mM Tris-HCl pH 7, 
150mM NaCl, 1.5mM MgCl2, 0.5% NP-40; 10 min, 4°C). The lysate was pelleted (1200 
RPM, 5 min), the supernatant was used for cytoplasmic buffer, and the remaining pellet was 
washed (3 times with cytoplasmic lysis buffer, 10 min). After the final wash, the cell pellet 
was lysed with nuclear lysis buffer (50mM Tris-HCl pH 7, 150mM NaCl, 1.5mM MgCl2, 
0.1% SDS, 0.5% sodium deoxycholate, 1% NP-40), the lysate was pelleted (13,000 RPM, 
10 min) and the supernatant was used for the nuclear fraction.
Clonogenic survival assay
Cells were seeded (3–5 × 105 cells/well) and then transfected with expression vectors for 
HOTAIR or vector alone (10µg) 24 hrs after seeding using Turbofect (Thermo). At 24 hr 
post-transfection, cells were treated with CDDP for 3 hrs, washed, serially diluted, plated in 
triplicate into 6 well plates, allowed 6–8 days of cell growth for colony formation, stained 
with 5% crystal violet, and cell count was normalized to untreated control as described [54].
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Mouse xenograft experiments
All animal studies adhered to ethical regulations and protocols approved by the Institutional 
Animal Care and Use Committee of Indiana University. To assess tumorigenicity of cells 
overexpressing HOTAIR, A2780p cells were transfected with pAV5S–HOTAIR or pAV5S–
aptamer and 24 hr post-transfection cells were treated or not with CDDP for 3 hr, washed 
with PBS trypsinized and counted with trypan blue, re-suspended in 1:1 PBS/matrigel (BD 
Bioscience) and injected subcutaneously into the left flank of 3- to 4- week-old female nude 
athymic mice (BALB/ c-nu/nu; Harlan, Indianapolis, IN), as described [54, 55]. Engrafted 
mice (4 per group) were inspected three times per week for tumor appearance by visual 
observation and palpation. Tumor length (l) and width (w) were measured weekly using 
digital calipers and tumor volume (v) was calculated as v=½ × l × w2. No randomization 
was used and no animals were excluded from the final data. The investigator measuring 
tumor size was blinded to the treatment groups. Mice were sacrificed when tumor diameter 
reached 2 cm or at the end of study.
ELISA and cytokine release assays
Conditioned media were prepared by washing culture plates with PBS followed by 
incubation in serum-free RPMI medium with antibiotics for 48 hr and stored at −80°C. Total 
cell counts were determined and ELISA was performed using kits and procedures from 
R&D systems (Minneapolis, MN. Cytokine release assay, Cat #ARY005) and eBiosciences 
(San Diego, CA. IL-6 ELISA Cat # 88-7066-22). The data were normalized to the cell 
number and reported as fold change. IL-6 release assay was performed 3 times and the 
cytokine release assay was performed once.
Immunofluorescence quantification
A2780p cells transfected with HOTAIR expression plasmid or vector control were plated on 
glass slides (50,000 cells/well), incubated overnight 4°C with anti-phospho-H2AX or anti-
p65 antibodies (See Supplementary Table S2), and the number of cells displaying nuclear 
p65 or γ-H2AX was determined in ten random images from 3 independent experiments 
using a light microscope (60X magnification). Fluorescence intensity was analyzed using 
image J software. To determine the difference in intensity, whole cell individual intensities 
and the nuclear intensity were measured, intensities were averaged and normalized to 
control to determine fold translocation
ChIP assays
Cells were cross-linked (1% formaldehyde) and dynabeads (Life Technologies) coupled to 
the appropriate secondary antibody were used to immunoprecipitate sheared chromatin 
extracts treated with anti-p65. After reversing the crosslinks, DNA was purified, and 
standard curve of ChIP input DNA was prepared. Enrichment was calculated by using qPCR 
to compare the level of the target region in each sample to the mean of negative control 
genomic regions. Primers designed for the specified genomic regions (Integrated DNA 
Technologies, Coralville, Iowa) amplified a single product from input DNA based on a 
single melting peak (Supplementary Table S4). Each ChIP DNA sample was assayed for the 
levels of negative control regions.
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Senescence-detection assays
Senescence-associated β-galactosidase was detected in A2780p cells fixed with 5% 
formaldehyde and incubated in staining solution (Sigma) and 1mg/ml 5-bromo-4-chloro-3-
indolyl β-d-galactosidase (X-Gal, Invitrogen), for 24 hr at 37 °C cells, following the protocol 
of Debacq-Chainiaux [31]. The number of distinct blue cells were counted (20X 
magnification) and normalized to the total number of cells.
RNA-sequencing analysis of A2780p and A2780_CR5 cells
Stranded whole transcriptome RNA-seq was performed essentially as we have described 
[56]. Briefly, biological duplicates of A2780p and A2780_CR5 cells (107 culture dish) were 
lysed and RNA was extracted according to manufacturers protocol (Qiagen RNeasy Mini 
kit). Total RNA was size fractionated by size using ethanol concentration manipulations. 
The large RNA fraction (>200 nt) was fragmented prior to library construction. Ribosomal 
RNA was reduced by duplex specific nuclease (DSN) following limited hybridizations of 
both fractions and then amplified to add barcodes for multiplexing on the Illumina 
HiSeq2000 platform. Demultiplexing was performed by CASAVA v1.8.2 and trimming was 
accomplished with Trimmomatic v0.22 with additional trimming by fastx_clipper v0.0.13.2. 
Read mapping was performed by tophat2 v2.0.6 to the human genome hg19 (UCSC) with 
Gencode annotation v13 allowing no more than two mismatches. RNA sequencing data can 
be accessed using SRA number SRP066008.
TCGA Analysis
The IlluminaHiSeq RNASeq data was provided by the Genome Sciences Centre, BCCA. 
The RPKM values were provided from TCGA database. The exon-exon junction sequences 
and their corresponding coordinates were defined based on annotations of any transcripts in 
UCSC known genes, Ensembl (v54) or the Refseq database (as downloaded from the UCSC 
genome browser on March 2009).
Statistical analysis
All data are presented as mean values ± SD of at least three biological experiments unless 
otherwise indicated. CDDP IC50 values were determined by Prism 6 (GraphPad Software, 
San Diego, CA), using logarithm normalized sigmoidal dose curve fitting. The estimate 
variation within each group were similar therefore student’s t-test was used to statistically 
analyze the significant difference among different groups by using Prism 4.0 (GraphPad 
Software). The genome-wide analysis experiments were conducted as described 
previously[56, 57] using the Partek Genomics Suite (version 6.5).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. HOTAIR expression and characterization in ovarian cancer (OC) cells
(A) HOTAIR expression in OC cell lines (IGROV, OVSAHO, OVMUNA, SKOV3, A2780, 
HEYC2, A2780-CR5, and OV90) was determined by qRT-PCR, (values normalized to 
GAPDH). Values represent the average of three biological replicates. (B) HOTAIR 
expression in primary high-grade serous ovarian tumors from unpaired patient samples at 
initial diagnosis and platinum sensitive (n=11) compared to patients with recurrent and 
platinum resistant disease (n=14) (C) TCGA data analysis for HOTAIR Read Per Kilobase 
Million (RPKM) values in OC patients with primary vs. recurrent disease. (D) Clonogenic 
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growth in A2780p overexpressing HOTAIR (left and middle graphs) and A2780_CR5 cells 
with dsiRNA-mediated depletion of HOTAIR. Graphs represent the fraction of surviving 
cells normalized to untreated population. Graphs represent triplicate experiments. (E) 
Xenograft tumor growth in athymic mice of A2780p expressing HOTAIR and treated with 
cisplatin (10µM CDDP) or vehicle control (2×106 cells per injection). Area under the curve 
(AUC) was calculated at 10 weeks (n=4 mice per group). Asterisks indicate P<0.05 (*) or 
P<0.01 (**).
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Figure 2. DNA damage induces HOTAIR expression
(A) A2780p cells transfected with HOTAIR or empty vector or (B) A2780_CR5 cells 
transfected with either dsiGFP or dsiHOT and were treated with CDDP (24 hr post-
transfection). Western blots show total Chk1 and pChk1 levels at the indicated times post-
CDDP treatment at the same exposure for both cell types. Western is representative of three 
biological replicates. (C) A2780p cells transfected with HOTAIR or vector control or (D) 
A2780_CR5 cells transfected with either dsiGFP or dsiHOT were untreated or treated with 
CDDP (10 µM). Cells were fixed and stained for γ-H2AX foci (red) at the indicated time 
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points. Cells were counted at 60x magnification (average of 100 cells counted) and the total 
number foci were determined. All experiments were repeated three times and error bars 
represent standard deviation (S.D.). (E) HOTAIR or vector expressing A2780p or 
A2780_CR5 cells transfected with either dsiGFP or dsiHOT were treated with indicated 
concentration of CDDP for 3 hrs and 24 hrs post-treatment caspase 3/7 cleavage assay was 
performed. Bar graph represents caspase 3/7 cleavage normalized to untreated control. 
Western blot is representative of two biological replicates. Asterisks indicate P<0.05 (*) or 
P<0.01 (**).
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Figure 3. HOTAIR overexpression induces DDR and NF-κB target gene expression
(A) Western blot showing total Iκ-Bα and p65 NF-κB levels in cytoplasmic and nuclear 
fractions in A2780 and A2780-CR5 cells. (B) Western blot showing total Iκ-Bα levels in 
cells expressing vector control or HOTAIR post CDDP-treatment (10µM) at indicated times. 
(C) A2780p cells transfected with HOTAIR or vector control were untreated or treated with 
CDDP (10 µM) for the indicated times. Cells were fixed and stained for NF-κB p65 (red). 
The total number of foci was determined based on the average of 100 cells counted at 60x 
magnification. Bar graph represents fold change of p65 translocation relative to untreated. 
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All experiments were repeated three times and error bars represent standard deviation (S.D.). 
(D) Western blot showing nuclear Iκ-Bα and NF-κB levels in A2780p cells expressing 
vector control or HOTAIR either post CDDP (10µM), Bay-11 (3 µM) or combination 
treatment. (E) A2780_CR5 cells transfected with either dsiGFP or dsiHOTAIR were 
untreated or treated with CDDP (10 µM) for the indicated times. Cells were fixed and 
stained for NF-κB p65 (red). The total number of foci was determined based on the average 
of 100 cells counted at 60x magnification. (F) Western blot showing nuclear Iκ-Bα and NF-
κB levels in A2780_CR5 transfected with either dsiGFP or dsiHOTAIR siRNA post CDDP 
(10µM), BAY11 (3 µM) or combination treatment.
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Figure 4. Transcriptional upregulation of HOTAIR by NF-κB during DNA damage
(A) HOTAIR expression in A2780p treated with CDDP alone or in combination with NF-κB 
inhibitor Bay-11 (HOTAIR levels measured by qRT-PCR 24hr post-treatment). (B) HOTAIR 
expression in A2780p cells transfected with IKK-α and IKK-β and western blot showing co-
expression of IKKα and IKKβ in A2780p cells 24 hr post-transfection. (C) Average 
expression (log10 fold change) of NF-κB target genes STAT1, IL6R, IL6, IL4R, IL8, IL1R1, 
BCL2L1, MMP9 in A2780p cells (red bars) HOTAIR expression (fold-change) was 
measured by normalizing to vector control. For A2780_CR5 cells transfected with 
dsiHOTAIR (yellow bars), fold change was measured by normalizing to dsiGFP transfected 
cells. (D) Average expression of NF-κB target genes measured in mouse xenografts 
overexpressing HOTAIR (treated with CDDP compared to untreated). Fold-change was 
measured by normalizing to xenografts with vector control. Bars represent average 
measurements +/−S.D. (n=4 per group). Asterisks indicate P<0.05 (*) or P<0.01 (**).
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Figure 5. Direct transcriptional regulation of HOTAIR by NF-κB
(A) Map of HOTAIR promoter region showing canonical p65 binding site (908 bases 
upstream of TSS) and the mutant generated in PGL3 vector. (B) Chromatin 
immunoprecipitation (ChIP) in A2780_CR5 cells of NF-κB p65 targeting 5 regions 
upstream of HOTAIR transcription start site (TSS). (1: 10kb, 2: 8kb, 3: 5kb, 4: 908bp 
(consensus p65 site) and 5: 203bp). Asterisks indicate P<0.05 (*) or P<0.01 (**) (C) 
Chromatin immunoprecipitation (ChIP) in A2780_CR5 cells of NF-κB p65 post CDDP 
(10uM) or in combination with BAY11 (3uM) targeting regions 1 and 4 upstream of 
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HOTAIR transcription start site (TSS). (1: 10kb, 4: 908bp (consensus p65 site) with primer 
corresponding to IL8 promoter as a (+) control. (D) Luciferase activity of HOTAIR promoter 
(Illustrated in Fig. 5A) in A2780p cells treated with mitomycin C (MMC, 10µM), cisplatin 
(CDDP, 10µM) or hydrogen peroxide (H2O2, 0.5mM). (E) Luciferase activity of NF-κB p65 
wild-type or mutant HOTAIR promoter (Fig. 4C) in A2780p cells pre-treated Bay-11 (5µM 
for 1 hr) then treated with MMC (10µM), CDDP (10µM) or H2O2 (0.5mM). Asterisks 
indicate P<0.05 (*) or P<0.01 (**).
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Figure 6. HOTAIR-induced IL-6 secretion
(A) HOTAIR- or control-conditioned media was added to A2780p cells and the IC50 for 
CDDP was determined by MTT assay. IL-6 neutralizing antibody was added to HOTAIR-
conditioned media and IC50 for CDDP was compared to HOTAIR-conditioned media plus 
IL-6 neutralizing antibody. (B) Recombinant IL-6 (10 ng/mL) was added to serum-free 
culture media and IC50 for CDDP determined by MTT assay (vs. negative control). (C) 
A2780_CR5 cells transfected with dsiRNAs targeting HOTAIR was measured for IL-6 
secretion 72 hr post transfection. (D) Conditioned media from A2780_CR5 cells transfected 
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with dsiRNAs targeting HOTAIR was added to cells and the IC50 for CDDP was determined 
by MTT assay. (E) A2780p cells transfected with HOTAIR or vector were treated with 
CDDP (1µM, “Low CDDP”; 20µM, “High CDDP”). Western blot analysis was performed 
using specific antibodies at the indicated time points. Asterisks indicate P<0.05 (*).
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Figure 7. HOTAIR-induced cellular senescence
(A) Western blot for total p-p53 and p53 (Left) and total pChk1 or Chk1 (Right) in cells 
overexpressing HOTAIR or vector control with or without ATR inhibitor (5µM) followed by 
CDDP treatment (10µM). (B) HOTAIR or vector transfected A2780p cells or (C) dsiGFP or 
dsiHOTAIR transfected A2780_CR5 cells were treated with CDDP (20µM) in the presence 
or absence of Bay-11 (5µM) and then assayed SA-β-Gal activity to asses senescent cells. 
Positive cells (blue coloration) were counted at the indicated times using a microscope (20X 
magnification). (D) HOTAIR or vector was transfected in A2780 cells and 24 hr post 
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transfection cells were treated with 20uM CDDP for 24 or 48 hr. DNA content was 
measured by PI staining and flow cytometry. (E) A2780_CR5 cells were transfected with 
either dsiHOTAIR or dsiGFPand 24 hr post transfection cells were treated with 20uM CDDP 
for 24 or 48 hr. DNA content was measured by PI staining and flow cytometry. Asterisks 
indicate P<0.05 (*).
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